| a. |
To provide funding to priority biotechnology areas
and to bridge gaps between existing public and private
sector funding; |
| b. |
To complement existing public and private sector
funds and provide a comprehensive government grant
mechanism, encompassing the entire R&D value
chain, from pre-seed, seed to development &
commercialisation funding; |
| c. |
To attract and provide incentives to researchers
and companies to develop the biotechnology industry;
and |
| d. |
To provide funding and capital for bio-entrepreneurs
to commercialise viable biotechnology products and
services. |